Cited by 189Genomics and Phylogenetic StudiesGenomics and Rare DiseasesGene expression and cancer classification

What would you do if you could sequence everything?

Open access
Kahvejian, Avak, Quackenbush, John, Thompson, John F·2008·Nature Biotechnology

Abstract

It could be argued that the greatest transformative aspect of the Human Genome Project has been not the sequencing of the genome itself, but the resultant development of new technologies. A host of new approaches has fundamentally changed the way we approach problems in basic and translational research. Now, a new generation of high-throughput sequencing technologies promises to again transform the scientific enterprise, potentially supplanting array-based technologies and opening up many new possibilities. By allowing DNA/RNA to be assayed more rapidly than previously possible, these next-generation platforms promise a deeper understanding of genome regulation and biology. Significantly enhancing sequencing throughput will allow us to follow the evolution of viral and bacterial resistance in real time, to uncover the huge diversity of novel genes that are currently inaccessible, to understand nucleic acid therapeutics, to better integrate biological information for a complete picture of health and disease at a personalized level and to move to advances that we cannot yet imagine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nbt1494

Cites

116 of 116 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

4 of the 120 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kahvejian, A., Quackenbush, J., & Thompson, J. F.
Affiliations
  • Helicos Biosciences (United States) (US)
  • Dana-Farber Cancer Institute (US)
Corresponding author
Quackenbush, John
Venue
Nature Biotechnology
Published
2008-10
Volume
26
Issue
10
Pages
1125-1133
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W2087444873
Cited by
189
References
120
Citations by year
2025: 5 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 11 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 7 · 2015: 9 · 2014: 10 · 2013: 18 · 2012: 18
FWCI
10.61
Type
journal article
Language
en
Open access
Locations
  • Nature Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5r01lm010129-02)
  • U.S. National Library of Medicine (R01-LM010129)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
Keywords
next-generation sequencing, Human Genome Project, sequencing technology development, genome regulation, gene discovery, nucleic acid therapeutics, personalized medicine, array-based technologies
MeSH terms
Chromosome Mapping, Forecasting, Health Knowledge, Attitudes, Practice, Human Genome Project, Sequence Analysis, DNA, Databases, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review